Consumer health products giant Johnson & Johnson is under fire for the latest in the string of what the FDA has found to be defective products that could potentially result in medical malpractice cases in New York and across the country.
According to FoxNews, the revelation of faulty diabetic insulin pumps follows a stunning string of 30 product recalls in just the last two years. Those recalls have included everything from headache medicine that reportedly didn't have the proper dosage of active drugs to contact lenses that burned the eyes.
Our New York City medical malpractice attorneys believe you should be able to expect safety when using FDA-approved health care products. But as these incidents illustrate, consumers must constantly pay attention not only to product recalls, but to the hazards of approved devices in the marketplace.
In this case, what has regulators furious is not simply the fact that the insulin pumps were faulty - even resulting in the hospitalization of three people who experienced perilously high blood sugar and respiratory failure. It is the fact that Johnson & Johnson delayed reporting two of those incidents and failed to report the other altogether.
The pumps provide life-saving shots of insulin to diabetic patients. In this case, the FDA reports, the pumps were not administering the proper dosage and the key pads on the pumps were also faulty. But, they said, the company continued to sell them anyway.
Erik Gordon, professor of Michigan's Ross School of Business, told FoxNews that to have one or two of these incidents might be a coincidence. Given the sheer volume of problems Johnson & Johnson has had, however, points to a more serious problem.
Last year, recalls cost the company an estimated $900 million in lost revenues.
The FDA has ordered an explanation from the company, and is continuing to investigate. The company also manufacturered the DuPuy hip, which is under recall.
No Comments
Leave a comment